Try our business solution for free!

Drugs in R&D pipeline worldwide 2021 vs. 2022, by phase of development

Published by
Matej Mikulic,
May 11, 2022
This statistic shows the number of drugs in the R&D pipeline worldwide in 2021 and 2022, by phase of development. At the begin of 2022, there were 11,351 drugs in the pre-clinical phase of the R&D pipeline.

Number of drugs in the R&D pipeline worldwide 2021 vs. 2022, by development phase

Loading statistic...

© Statista 2023
You need to log in to download this statistic
Register for free
Already a member?
Log in
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

2022

Region

Worldwide

Survey time period

2021 and 2022

Supplementary notes

* As of January 2022.

Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Pharmaceutical industry in Norway "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Statistics on Pharmaceutical industry in Norway

Overview

5

Pharmaceutical revenue

5

Production and trade

4

R&D, patents and new products

4

Further related statistics

17

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical research and development (R&D)Global pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsCoronavirus (COVID-19) vaccines and treatments
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.
Menu